NURO: Neurometrix Inc. Company Profile & Statistics

About

Neurometrix is a medical device company establishing a new standard of care through the design, development and sale of proprietary products used to diagnose neuropathies. Neuropathies are diseases of the peripheral nerves and parts of the spine that frequently are caused by or associated with diabetes, low back pain and carpal tunnel syndrome, as well as other clinical disorders.

Info & Links

CEO

Shai N. Gozani

Headquarters

4B GILL STREET WOBURN,
MASSACHUSETTS, MA 01801, UNITED STATES

Auditor

Baker Tilly US, LLP

Share holders

Employees

Neurometrix Inc. Statistics

Valuation Measures

Market Capitalization²

8.02M

Enterprise Value

7.10M

Enterprise Value/EBITDA(ttm)

-0.83

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

2.15

Price to Book(mrq)

0.50

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

57.18%

Operating Margin(ttm)

-203.71%

Profit Margin(ttm)

-213.12%

Return on Equity(ttm)

-42.56%

Return on Invested Capital(ttm)

-42.40%

Return on Assets(ttm)

-39.26%

Income Statement

Revenue(ttm)

3.77M

Revenue Per Share(ttm)

1.84

Gross Profit(ttm)

2.17M

EBITDA(ttm)³

-8.54M

Net Income Available to Common(ttm)

-7.68M

Diluted EPS(ttm)

-4.59

Share Statistics

Beta (5Y Monthly)

2.20

52-Week Change

5.08%

S&P 500 52-Week Change

23.90%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

2.04M

Dividend Yield

0.00%

Float⁴

1.95M

% Held by Insiders

4.40%

% Held by Institutions

19.40%

Balance Sheet

Total Cash(mrq)

14.83M

Total Cash Per Share(mrq)

7.26

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

13.88%

Quick Ratio(mrq)

12.70%

Book Value Per Share(mrq)

7.86

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.59

Free Cash Flow(ytd)

-5.24M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

NURO

Neurometrix Inc.

Neurometrix Inc. Profile